InhibOx
InhibOx creates faster ways to identify and develop new antibiotics for drug-resistant infections. The company uses AI and computational biology to model molecules and predict activity, focusing on its antibiotic discovery pipeline. Its core technologies include AI, machine learning, and computational drug discovery for ligand- and structure-based screening. Target customers are biotechnology and pharmaceutical companies seeking early discovery support. The platform aims to scale discovery and help bring novel antibiotics to market faster.
InhibOx
InhibOx creates faster ways to identify and develop new antibiotics for drug-resistant infections. The company uses AI and computational biology to model molecules and predict activity, focusing on its antibiotic discovery pipeline. Its core technologies include AI, machine learning, and computational drug discovery for ligand- and structure-based screening. Target customers are biotechnology and pharmaceutical companies seeking early discovery support. The platform aims to scale discovery and help bring novel antibiotics to market faster.